Cargando…

Combination therapy with interferon and ruxolitinib for polycythemia vera and myelofibrosis: are two drugs better than one?

Detalles Bibliográficos
Autor principal: Silver, Richard T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556626/
https://www.ncbi.nlm.nih.gov/pubmed/33054041
http://dx.doi.org/10.3324/haematol.2020.256602
_version_ 1783594260215365632
author Silver, Richard T.
author_facet Silver, Richard T.
author_sort Silver, Richard T.
collection PubMed
description
format Online
Article
Text
id pubmed-7556626
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Fondazione Ferrata Storti
record_format MEDLINE/PubMed
spelling pubmed-75566262020-10-15 Combination therapy with interferon and ruxolitinib for polycythemia vera and myelofibrosis: are two drugs better than one? Silver, Richard T. Haematologica Editorials Fondazione Ferrata Storti 2020-09-01 /pmc/articles/PMC7556626/ /pubmed/33054041 http://dx.doi.org/10.3324/haematol.2020.256602 Text en Copyright© 2020 Ferrata Storti Foundation http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Editorials
Silver, Richard T.
Combination therapy with interferon and ruxolitinib for polycythemia vera and myelofibrosis: are two drugs better than one?
title Combination therapy with interferon and ruxolitinib for polycythemia vera and myelofibrosis: are two drugs better than one?
title_full Combination therapy with interferon and ruxolitinib for polycythemia vera and myelofibrosis: are two drugs better than one?
title_fullStr Combination therapy with interferon and ruxolitinib for polycythemia vera and myelofibrosis: are two drugs better than one?
title_full_unstemmed Combination therapy with interferon and ruxolitinib for polycythemia vera and myelofibrosis: are two drugs better than one?
title_short Combination therapy with interferon and ruxolitinib for polycythemia vera and myelofibrosis: are two drugs better than one?
title_sort combination therapy with interferon and ruxolitinib for polycythemia vera and myelofibrosis: are two drugs better than one?
topic Editorials
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556626/
https://www.ncbi.nlm.nih.gov/pubmed/33054041
http://dx.doi.org/10.3324/haematol.2020.256602
work_keys_str_mv AT silverrichardt combinationtherapywithinterferonandruxolitinibforpolycythemiaveraandmyelofibrosisaretwodrugsbetterthanone